Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-18-004006
Filing Date
2018-04-03
Accepted
2018-04-03 17:55:04
Documents
1
Period of Report
2018-04-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3040218vitolo_relmada.html 3  
1 OWNERSHIP DOCUMENT f3040218vitolo_relmada.xml 3 4120
  Complete submission text file 0001213900-18-004006.txt   5553
Mailing Address 275 MADISON AVENUE, SUITE 702 NEW YORK NY 10016
Business Address 275 MADISON AVENUE, SUITE 702 NEW YORK NY 10016 646-677-3853
RELMADA THERAPEUTICS, INC. (Issuer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 71 WESTLAND AVENUE NEWTON MA 02465
Business Address
Vitolo Ottavio V. (Reporting) CIK: 0001736257 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55347 | Film No.: 18734905